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Abstract The translational challenge in biomedical research lies in the effective
and efficient transfer of mechanistic knowledge from one biological context to an-
other. Implicit in this process is the establishment of causality from correlation in the
form of mechanistic hypotheses. Effectively addressing the translational challenge
requires the use of automated methods, including the ability to computationally cap-
ture the dynamic aspect of putative hypotheses such that they can be evaluated in a
high throughput fashion. Ontologies provide structure and organization to biomedi-
cal knowledge; converting these representations into executable models/simulations
is the next necessary step. Researchers need the ability to map their conceptual mod-
els into a model specification that can be transformed into an executable simulation
program. We suggest this mapping process, which approximates certain steps in the
development of a computational model, can be expressed as a set of logical rules,
and a semi-intelligent computational agent, the Computational Modeling Assistant
(CMA), can perform reasoning to develop a plan to achieve the construction of an
executable model. Presented herein is a description and implementation for a model
construction reasoning process between biomedical and simulation ontologies that is
performed by the CMA to produce the specification of an executable model that can
be used for dynamic knowledge representation.
Keywords Executable biology · Simulation methods · Agent-based systems ·
Artificial intelligence · Knowledge representation · Automated reasoning
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1 Introduction
The biomedical research community faces a challenge manifest as the discrepancy
between an increasing amount of basic mechanistic knowledge about biological pro-
cesses and the inability to effectively translate that mechanistic knowledge into clini-
cally effective therapeutics. The divergence between basic science knowledge and the
delivery of effective therapeutics was noted by the United States Food and Drug Ad-
ministration in a 2004 report: “Innovation or Stagnation: Challenge and Opportunity
of the Critical Path to New Medical Products,” where, despite increasing expenditures
on basic science research, there was a downward trajectory in terms of the number
of new therapies that reached the bedside (USFDA 2004). This is the essence of the
translational dilemma in biomedical research, and appears to be particularly evident
when investigating systems diseases, where there are disturbances of internal system-
level regulatory mechanisms, such as cancer, autoimmunity, diabetes and sepsis. We
suggest that there are fundamental process issues present in the biomedical research
workflow that lead to the current translational dilemma. Characterization and iden-
tification of these process issues are a necessary step in the rational development of
strategies to address the translational dilemma.
1.1 The roots of the translational dilemma
A recent review has examined the roots of the translational dilemma (An 2010) and
a summary of its assertions is below:
As primarily an applied science, the ultimate goal of biomedical research is to
identify and affect control on biological systems moving between states of health
and disease. Effecting control requires an approximation of mechanistic causality,
as planned interventions must have their basis in some imputed causal mechanism.
Identification of correlative relationships do not amount to identifications of causal-
ity, therefore a means of testing causality must be incorporated into any knowledge-
expansion process. Since the complete and comprehensive description of a biological
system is impossible (i.e. a putative solution based on just obtaining more data will
not suffice), a more efficient means of evaluating the sufficiency of the current state of
knowledge must be established, where sufficiency is defined as establishing enough
trust in a presumptive mechanistic hypothesis such that the hypothesis is useful in
designing a means of control. The biomedical research community is in a situation
where the balance of the scientific method (conversion of observations/data into pat-
terns/hypotheses via correlation leading to testing of presumptive causality via ex-
periment) has dramatically shifted towards the correlative component. The advent
of the high throughput data environment has led to an increasing range of possible
explanatory hypotheses, while the ability to evaluate those hypotheses through test-
ing remains a time consuming, linear task. As such, where establishing correlation
has become parallelized, testing causality remains a serial process. Adding to the
challenges posed by this situation are the hierarchical organization and multi-scale
nature of biological systems, resulting in epistemological boundaries to human intu-
ition and synthesis, such that mechanistic hypotheses cannot be merely aggregated to
obtain system-level behavior. The overall process of biomedical research is therefore
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limited in both (1) the breadth of hypothesis testing (throughput problem) and (2)
complexity of hypotheses (multi-scale problem). These issues point to the need to
enhance representation and examination of mechanistic hypotheses to facilitate the
identification and evaluation of plausible solutions. Automation aimed at augmenting
the rate-limiting steps of the scientific process is therefore a reasonable strategy for
the future. More specifically, the need to represent the dynamics of a putative hypoth-
esis and the imputed paths of causality within that hypothesis is greatly enhanced by
the use of computational modeling and simulation (M&S) as a means of instantiated,
dynamic knowledge representation. Furthermore, the need to provide a scalable so-
lution means that this use of M&S must be augmented via semi-automation of the
simulation-creation workflow. Advancing the process of dynamic biological knowl-
edge representation involves: (1) formalizing the expression of biomedical knowl-
edge, (2) being able to tie those representation formats to a classification of M&S
methods and approaches, and (3) doing so in a manner that limits the intellectual
overhead of non-computer experts among the biomedical research community, which
in essence requires the proposed process to generate executable code for simulations.
Restated, developing scalable dynamic knowledge representation involves leveraging
existing biomedical knowledge representation achieved through ontologies, linking
knowledge thus represented with M&S methods to produce dynamics, and semi-
automating the process by which this transfer occurs. In the following sections we
will deal with each of these steps.
1.2 Biomedical ontologies
Ontologies are knowledge classification systems that provide a structured vocabu-
lary and taxonomy for a particular scientific domain. The benefits of such classifi-
cation systems include: providing organizational structure to an established corpus
of knowledge, allowing a contextual placement of existing and new research, al-
lowing navigation within a particular domain and identification of intersections of
knowledge, providing a frame of reference with respect to existing and new ter-
minology, and providing a knowledge base amenable to automated inference with
respect to expanding relationship structure. Ontologies emphasize class-structures,
properties and taxonomic relationships between the constitutive concepts within the
domain. The Web Ontology Language (OWL) and the Resource Description Frame-
work (RDF) currently specify the descriptive capacity of ontologies. This descriptive
capacity generally consists of a collection of facts and axioms that define the knowl-
edge about classes, properties and individuals in the ontology. Ontology development
methods have expanded into the area of bioinformatics, and as such biomedical on-
tologies follow these conventions. Bio-ontologies are currently found in an online
repository, BioPortal (http://bioportal.bioontology.org), which is managed by the Na-
tional Center for Biomedical Ontologies (NCBO) (http://www.bioontology.org). The
NCBO has ongoing development of computational and bioinformatics tools to in-
crease the utility of bio-ontologies for the biomedical community at large. Addition-
ally, the OBO Foundry (http://www.obofoundry.org) is a collaborative project that
is focused on establishing principles for biomedical ontology development with the
goal of growing a group of interoperable ontologies to be used in the biomedical
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arena; a substantial number of the ontologies found in BioPortal originate from the
OBO Foundry.
However, despite their usefulness, ontologies/bio-ontologies have a significant
limitation in terms of their expressiveness given the goal of evaluating the dynamic
behavior of mechanistic hypotheses. Current ontologies generally utilize a limited
predicate set focused on classifying objects, concepts and relationships between
them, allowing logical inference and proof of the internal consistency of a statement,
but not being able to represent any of the dynamic consequences associated with that
relationship. Therefore, there is a critical need to expand the predicate expressiveness
to “actions” or “functions” to allow the expression of rules necessary to generate dy-
namics. To some degree, terms corresponding to these function predicates already
exist in BioPortal ontologies, but they exist as adjectives that can be applied to other
noun-concepts in the various ontologies. For instance, in the Gene Ontology there
is class called “Molecular_Function” (GO:0003674) that lists a series of possible
functional roles for molecules, such as “Enzyme Regulator Activity” (GO:0030234).
However, this in the form of an adjective, and would need to be converted into its verb
form in order to be used in a rule. For example, such a rule might be “Compound A
modulates the activity of Enzyme B.” The ability to express a rule would require a
concatenation of terms from different ontologies, and also may require some transfor-
mation of the form of the ontological term. There is already some recognition of these
limitations of OWL in the area of Semantic Web research, with ongoing development
in languages such as Rule Markup Language (RuleML) (http://www.ruleml.org) and
Semantic Web Rule Language (SWRL) (http://www.w3.org/Submissions/SWRL/).
The need to use rules to instantiate dynamics moves knowledge representation to-
wards the realm of modeling and simulation (M&S).
1.3 Ontologies in modeling and simulation
As in the biomedical arena, there is interest in the use of ontologies in the area of
M&S, particularly in terms of the development and use of ontology-driven M&S
(Yilmaz 2007; Miller et al. 2004; Petty and Weisel 2003; Fishwick and Miller 2004;
Benjamin et al. 2006). The advantages of an ontology-driven approach can be seen in
the development of M&S standards for interoperability, modularity, use of legacy
codes/models and federated simulation (Benjamin et al. 2006). The key concept
underlying these projects is that of composability: the ability to select and assem-
ble simulation components in various combinations to meet specific simulation use
goals (Benjamin et al. 2006; Petty and Weisel 2003). Performing simulation com-
position is recognized as a dynamic process that evolves during the course of a re-
search/experimental program (Yilmaz 2007), an important realization in terms of ad-
dressing the translational challenge. There has also been significant work on the de-
velopment of ontologies for M&S methods, such as the Discrete-event Modeling On-
tology (DeMO) proposed and developed by Miller and Fishwick (Miller et al. 2004;
Fishwick and Miller 2004; Silver et al. 2011). DeMO is a “classical” ontology that
relies upon a hierarchical “IS/A” class-subclass organizational structure. This allows
the application of automated inference methods on DeMO knowledge structures, as
is possible with bio-ontologies, but also means that the dynamic expressiveness of
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a M&S structure within DeMO is limited. However, utilizing the concept of com-
posability along with the domain-specific knowledge in a M&S ontology allows the
creation of computational objects that can effectively capture dynamics.
1.4 Ontology concatenation for dynamic knowledge representation
As noted above limitations of the expressiveness of OWL and existing ontologies are
based in the inability of current ontologies to express rules. Rules form the basis for
instantiating mechanistic relationships, and the ability to express rules forms the key
step in moving from static knowledge representation to dynamic knowledge repre-
sentation. Expressing rules requires extending predicate logic systems to statements
that denote functions or actions. This will allow the statements to be converted to
dynamic models and simulations, fulfilling a critical role in the use of modeling in
biology in overcoming the Translational Dilemma. Due to the complexity of the re-
lationships in biology and the uncertainty with respect to its constitutive statements
the importance of a biological model requires not only an assessment of its internal
consistency (veracity) but also its mapping to the real world (validity). A biologi-
cal conceptual model based on a purely logical formalism does not have sufficient
expressiveness to assess the application of that conceptual model to the real world:
the internal “correctness” of the logical formalism (“true/false”) does not provide
enough information to correlate to real world measurements. Since the expression of
functional/actionable predicate relationships within an ontology is not possible us-
ing OWL, we propose the concatenation of knowledge components from biomedical
ontologies using function-representing structures from M&S methods. A key point
to this proposal is that while an ontology of M&S methods is limited in its expres-
siveness to relational predicate statements, the domain knowledge associated with
each M&S object/class contains, by necessity given the nature of the M&S domain,
a formal description of the simulation method (see DeMO) and therefore becomes
the core data for the formal system used to generate the dynamic model. It should be
noted that a logical model can be constructed that operates upon either a relational
predicate or functional/actionable predicate statement (i.e. a computer program that
utilizes the syntax of the statement as a data structure). We propose to use the logical
inference capability of a formal system to augment the ability of researchers to op-
erate in the real world. The key to this argument has to do with the different realms
between the operations of logic and determinations of “truth” within the knowledge
structure, and the relationship between the relationship structure and the real world
(validity). Herein we identify a series of formats and protocols to facilitate the pro-
cess of dynamically composing simulations such that a computational agent can be
developed to exercise those protocols.
1.5 Prior work in computational discovery of scientific knowledge
The past few decades has seen increasing research in the computational discov-
ery of scientific knowledge (Džeroski et al. 2007). While originally envisioned as
the development of computer systems that could produce new scientific discover-
ies on par with a human scientist (Langley 2000), the field has grown to encom-
pass creativity processes and computational augmentation of the scientific method
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both with and without the involvement of the human scientist, i.e. human-in-the-loop
and human-out-of-the-loop. Initial research led to the distinction between scientific
knowledge structures and scientific activities. Scientific knowledge structures con-
stitute the primary products of the scientific endeavor and consist of taxonomies
(or ontologies), laws and theories. Scientific activities are the formation and revi-
sion of those scientific knowledge structures, and those activities typically utilize
intermediate knowledge structures such as models and experiments to aid in the
task. Computational creativity attempts to expand beyond the artificial intelligence
problem-solving paradigm, with its well-defined goals and algorithms to achieve
them, into an artifact-generating paradigm that incorporates cognitive aspects of cre-
ativity and social and cultural interactions (Colton et al. 2009; Chen et al. 2009;
Shneiderman 2007). Computational creativity goes beyond scientific discovery to
include other creative tasks such as writing poems and jokes, composing music
and painting pictures. Computational augmentation of the scientific process fo-
cuses upon those intermediate knowledge structures to increase productivity and ef-
fectiveness of the primary scientific activities. Through development of computer
tools, example augmented tasks include generation and evaluation of models (Yil-
maz and Hunt 2011; Bridewell et al. 2006), design of experiments (Zytkow et al.
1992), aggregation and management of scientific knowledge (Antezana et al. 2009;
Rzhetsky et al. 2000), and construction of scientific workflows (Goecks et al. 2010;
Hull et al. 2006; Linke et al. 2011). The research presented in this article falls in the
latter category of computational augmentation, specifically the automation of con-
structing computational models from biological knowledge.
Computational discovery is a daunting task, and for that reason much research has
concentrated on the manipulation of well-defined formal structures such as mathe-
matical statements (Montano-Rivas et al. 2010), mathematical equations (Krishna-
murthy and Smith 1994; Atanasova et al. 2006), and logic programs (Zupan et al.
2007; Karp 2001). Consequently, there has been considerable advance in artificial in-
telligence algorithms to perform deductive, inductive (Colton and Muggleton 2006;
Montano-Rivas et al. 2010; King et al. 2007) and abductive (Prendinger and Ishizuka
2005; Zupan et al. 2007) reasoning for scientific discovery, heralding the day of
the robot scientist (King et al. 2009). Furthermore, data mining and machine learn-
ing have introduced a new parallel paradigm where patterns are discovered from
large data sets, leading to an explosion of bioinformatic tools to analyze and man-
age the data produced from high-throughput biology experiments and accumulated
in biological databases. However, while artificial intelligence approaches have suc-
ceeded for some disciplines, such as mathematics and physics where the underly-
ing axioms and physical laws are well established, they have been less success-
ful for biological discovery because the underlying laws that govern the behavior
of biological phenomena at higher organizational scales above the physical scale,
such as cells, tissues, organisms and ecosystems, are poorly understood. These or-
ganizational scales tend to require symbolic versus equation-based representations,
and those systems that have been implemented have focused on biochemical reac-
tion networks that draw upon decades worth of knowledge in molecular biology
and operate using the physical laws of chemistry (Karp 2001; Calzone et al. 2006;
Curti et al. 2004).
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Alternatively, our objective is to provide hypothesis evaluation across these multi-
ple organizational scales, and we maintain the human-in-the-loop as part of discovery
process because of the invaluable contribution provided by human intuition. To re-
duce the computer/programming expertise threshold for the researcher we utilize a
near-natural language representation for biological knowledge that allows hypothe-
ses to be expressed in the concise way that scientists expect. While this might make
the model construction task more difficult for the semi-intelligent agent, we con-
sider this an advantageous approach because it alleviates the problem with many
existing systems whereby the biologist must translate their knowledge into an in-
termediate modeling language. Our approach draws upon artificial intelligence re-
search but instead of attempting to automate discovery, we augment the scientist’s
own capability to evaluate hypotheses through modeling and simulation by facil-
itating the translation of biological knowledge into computational models. While
we recognize that in the future a more comprehensive computational augmenta-
tion tool would include aiding in the evaluation of models (Yilmaz and Hunt 2011;
Bridewell et al. 2006), design of experiments (Zytkow et al. 1992), and construction
of scientific workflows (Goecks et al. 2010; Hull et al. 2006; Linke et al. 2011), we
assert that computational augmentation of hypothesis representation and instantia-
tion is a necessary step towards these future goals. Therefore, in the next section,
we discuss the translation process from biological conceptual models into computa-
tional/mathematical model specifications in more detail and demonstrate our method
with two biological case studies.
2 Model construction
A critical step in developing a robust and scalable solution to the translational
dilemma is facilitating the adoption of dynamic computational modeling as a means
of knowledge representation within the general biomedical research community.
However, at this point in time, the threshold for the average biomedical researcher
to engage in computational and mathematical modeling remains prohibitive. The
process of transforming biological knowledge and data into computational models
requires specific expertise acquired through extensive training and experience. How-
ever, we suggest that certain aspects of the modeling process can be characterized al-
gorithmically and then embedded into computational agents to semi-automate model
construction. We suggest that the general adoption of M&S-enhanced hypothesis
instantiation/evaluation can be aided by the development of software entities that
we term a Computational Modeling Assistant (CMA). We propose the CMA as a
software tool that augments biological model construction by integrating biological
knowledge, computational modeling methodology, and expert-derived rules for map-
ping biological concepts to modeling methods. Figure 1 gives an overview of the
information flow for the interactions between the researcher and the CMA.
The CMA is intended to be agnostic to any specific modeling method, provid-
ing possible alternatives using multiple methods as different abstractions of the same
biological concept. This latter point is a significant issue, as different aspects of a
A proposal for augmenting biological model construction 387
Fig. 1 Overview of workflow and interaction between researcher, computation modeling assistant (CMA)
and various ontologies and knowledge databases
biological model may be best represented with different simulation methods, result-
ing in an increasing recognition of the importance of being able to construct hybrid
biological models.
2.1 Biological Example #1
To demonstrate how our proposed CMA would be used to instantiate and explore hy-
potheses for a biological mechanism, we consider as an initial example the formation
of the stratified mucus layer in the human colon.
2.1.1 Gut mucus stratification
Many epithelial layers produce and maintain a mucus layer that acts as an additional
barrier between the epithelium and the external or luminal environment. In the human
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colon, epithelial goblet cells secrete mucus that forms a stratified structure composed
of an inner “tight” mucus layer and an outer “loose” mucus layer (Johansson et al.
2010). The outer mucus layer is the habitat of the gut bacteria flora while the inner
mucus layer is attached to the epithelial cells and is normally devoid of bacteria, thus
providing a protective layer to prevent contact between bacteria and the epithelial
cells. It is not known how the inner mucus layer is converted into the outer mucus
layer, but it is known to be under host control (versus caused by bacteria) because
both layers form in bacteria-free mice. Also, mucus conversion is an active chemical
process performed by a molecule released by the epithelial cells, as there are no cells
in the mucus layer and conversion is inhibited in the inner layer.
We consider a hypothesized mechanism whereby epithelial cells release one or
more morphogens that form a spatial gradient where conversion is inhibited near the
cells and activated further away from the cells, resulting in the stratified mucus layers.
For our biological model, we consider two unknown genes A and B. Inside a cell, the
proteins for A and B are bound together into a protein complex AB that is secreted
from the cell. AB diffuses in the extracellular space and decays back into the A and
B proteins at some rate. Protein A then converts mucus from the tight to loose form,
while protein B decays. We formalize our biological model into a set of near-natural
language statements that have been annotated with their corresponding bio-ontology
term (Gene Ontology (GO), Systems Biology Ontology (SBO), Foundational Model
of Anatomy Ontology (FMA), and Physico-chemical Process Ontology (REX)) to
produce the enriched communicative biological model given below:
1. goblet cell [GO:0005623] has [GO:has_part] muc2 gene [SBO:0000243].
2. Muc2 gene is transcribed [SBO:0000183] into muc2 mRNA [SBO:0000278].
3. Muc2 mRNA is translated [SBO:0000184] into muc2 protein [SBO:0000252].
4. goblet cell [GO:0005623] has [GO:has_part] A gene [SBO:0000243].
5. A gene is transcribed [SBO:0000183] into A mRNA [SBO:0000278].
6. A mRNA is translated [SBO:0000184] into A protein [SBO:0000252].
7. goblet cell [GO:0005623] has [GO:has_part] B gene [SBO:0000243].
8. B gene is transcribed [SBO:0000183] into B mRNA [SBO:0000278].
9. B mRNA is translated [SBO:0000184] into B protein [SBO:0000252].
10. Goblet cell secretes [GO:0046903] muc2 protein into extracellular space
[GO:0005615].
11. A protein and B protein bind [SBO:0000177] to form AB complex
[SBO:0000296].
12. Goblet cell secretes AB complex into extracellular space.
13. Extracellular AB complex diffuses [REX:0000122].
14. Extracellular AB complex disassociates [SBO:0000180] into extracellular pro-
tein A and B.
15. Extracellular A protein diffuses [REX:0000122].
16. Extracellular B protein diffuses [REX:0000122].
17. Extracellular A protein decays [SBO:0000179].
18. Extracellular B protein decays [SBO:0000179].
19. Extracellular muc2 protein forms inner mucus layer [GO:0070702].
20. Extracellular A protein cleaves [SBO:0000178] extracellular muc2 protein.
21. Cleaved extracellular muc2 protein forms outer mucus layer [GO:0070703].
22. Colon epithelium [FMA:Epithelium_of_colon] is a 2D plane of cells.
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2.1.2 Intelligent agent composition
The CMA utilizes and leverages developments in formal knowledge representation
through the use of ontologies in biology and M&S by using an intelligent-agent ap-
proach based upon a logical framework. It performs automated reasoning to aid in
the construction of a computational model (and ultimately simulation code), treating
model construction as a planning task where the goal is translating a conceptual bi-
ological model into simulation code. The plan is divided into two parts: constructing
the model specification and producing the simulation code. As illustrated in Fig. 1,
construction of the model specification requires the integration of numerous knowl-
edge databases and ontologies. The researcher hypothesizes a conceptual biological
model in a near-natural language format such as demonstrated for gut mucus stratifi-
cation. This model is then supplemented with a database of existing biological knowl-
edge. Ontologies for biology and modeling concepts are then used with a knowledge
base of mapping rules to produce one or more model specifications.
The CMA produces multiple model specifications corresponding to alternative
modeling methods. For example, one specification might be for a continuous deter-
ministic model, while another may be a discrete stochastic model. The researcher
reviews those model specifications and chooses one or more for the CMA to produce
simulation code. This decision is based upon various factors: availability of certain
types of biological data, prior knowledge about the behavior of the biological sys-
tem and level of modeling detail. More than one model specification can be chosen,
maybe to compare the different models and determine whether the extra complexity
in one model over another is required for the particular biological problem of inter-
est. This is one reason why the human cannot be completely taken out of the loop:
because as all models are abstractions of reality, only the researcher has the intuition
to assess the usefulness of one model abstraction versus another for the biology being
studied.
Given a chosen model specification the CMA can produce simulation code us-
ing an ontology of numerical and simulation methods and logical rules to map the
model specification into code using particular methods. Here too there may be mul-
tiple choices for implementation, though these choices are primarily concerned with
stability and performance issues. While these are important issues, we do not explore
them further in this article.
2.1.3 Maude logical framework
We implement our system using Maude (Clavel et al. 2007). Maude is a logical frame-
work based on rewriting logic that is simple yet expressive. It provides capabilities
such as reflection and formal verification beyond other logical frameworks such as
CLIPS or Prolog. These additional capabilities are useful for the CMA as it can pro-
vide alternative models and analyze the knowledge database for inconsistencies or
gaps.
2.1.4 Biological knowledge representation
Three pieces of biological knowledge need to be represented within Maude in order
for the CMA to operate: a list of biomedical ontologies, existing biological knowl-
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Fig. 2 Biological statement #2
from the gut mucus stratification
model represented in the Maude
language as a set of operators
Fig. 3 Subsort hierarchy
identifying the biological entity
A-protein[e] as a material entity
edge and the conceptual biological model to be instantiated. In order for ontological
knowledge representations to be operated on by Maude, ontology data types need to
be translated into Maude structures. Towards this end, we translate ontological terms
into Maude sorts while the ontology’s IS/A hierarchy is represented by Maude sub-
sorts. Maude sorts correspond to types in programming language theory, so this pro-
vides us with customized ontology-derived data types for representing and reasoning
about the entities and processes in the biological and M&S knowledge.
The biological knowledge is represented as a series of biological statements
whereby the nouns and verbs of the statement are defined according to their ontol-
ogy term and thus a Maude sort. Figure 2 shows how statement #2 is represented in
Maude. The biological entities, muc2-gene and muc2-mRNA, are defined as constant
instances of the Maude sorts “gene” and “messenger RNA.” The biological process
of transcription is defined as a “transcribe” operator on a “gene” and a “messenger
RNA,” and is used to represent a biological statement. Lastly, the biological state-
ment that the muc2-gene is transcribed into muc2-mRNA is stated. Maude supports
polymorphism for operators so another transcribe operator could be defined that op-
erates on “pre-messenger RNA,” thus allowing for mRNA processing and alternative
splicing to be defined. This flexibility allows multiple levels of biological detail with
the appropriate level of abstraction chosen automatically by the types of biological
statements.
The diffusion operator shows how the IS/A ontology hierarchy is utilized. While
transcription is clearly defined as operating on a gene, many different biological enti-
ties can diffuse, thus the “diffuse” operator is defined for the general “material entity”
sort as can be seen in Fig. 3. The biological statement that “A-protein[e] (extracel-
lular A protein) diffuses” is valid because “A-protein[e]” IS/A “polypeptide chain”
IS/A “information macromolecule” IS/A “macromolecule” IS/A “material entity,”
according to the biomedical ontologies.
All of the biological statements are thus represented in Maude as logical state-
ments as shown in Fig. 4. As shown, these logical statements would correspond to a
set of facts that are asserted as true in other logic systems like CLIPS or Prolog. How-
ever, Maude allows for richer expression than propositional logic as in those logic
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Fig. 4 Biological model
expressed as a set of Maude
logical statements
systems, and the statements are closer to first-order logic that have been argued as
a more appropriate representation for scientific discovery (King et al. 2007), though
Maude is also capable of supporting higher-order logics. This current model lacks
some of the biological knowledge about goblet cells and their spatial arrangement
in an epithelium layer, which we consider in future work. Maude considers certain
biological statements invalid due either to incorrect specification of the biological
statement, or because Maude lacks a proper definition of the biological process or
entity.
2.1.5 Modeling knowledge representation
The modeling ontology is translated into Maude sorts and subsorts just as with the
biomedical ontologies. However the breadth of modeling ontologies is limited in
comparison to the biomedical ontologies; therefore we have had to extract this knowl-
edge from published M&S literature. Existing ontologies such DeMO and the Ontol-
ogy of Physics for Biology (OPB) offer starting points, but accurate and detailed
characterization of modeling methods require specific descriptions of mathemati-
cal entities such as variables, functions, arithmetic, derivatives, etc. Standards such
as OpenMath (http://www.openmath.org) and MathML (http://www.w3.org/Math/)
provide some formalization of mathematical knowledge but there are still many chal-
lenges related to attempts to catalog mathematical methods that are beyond the scope
of this paper. For our current work with the CMA, we have focused on building up a
small but sufficient ontology of common modeling methods. This work will continue
over time to incorporate additional methods into a more complete ontology.
2.1.6 Mapping rules
Transformation of biological knowledge into a model specification is described by
a set of Maude rewrite rules that take one or more biological statements and pro-
duce a modeling specification statement. The rules are specific to both the biological
statement and the modeling method used to represent the biology. It is these rules that
encapsulate the expert knowledge of modelers and the process of model construction.
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Fig. 5 Maude rewrite rules that describe how various biological statements are translated into a continuous
deterministic (ODE and PDE) model specification. Variables such A, B, C, S and M are declared as specific
Maude sorts related either to the biological model or the modeling method
A set of rewrite rules for the biological functions of transcription, translation,
degradation, binding, dissociation, secretion and diffusion can be seen in Fig. 5.
These specific rules produce a specification for a continuous model using ordinary
differential equations (ODE) or partial differential equations (PDE). Each left-hand
side of the rule matches a biological statement and the right-hand side of the rule
appends a model specification statement. For the transcribe rule which has two com-
ponents of the gene (G) and the resultant RNA (R), an ODE is specified for variable
R with a Hill function in the variable G. The secrete rule is more complicated with
four components of the source molecule (A), source spatial context (CA), the resul-
tant secreted molecule (B), and the resultant spatial context (CB). The secrete rule
results in two ODEs added to the model specification, one for the source molecule
A and one for the resultant secreted molecule B. The diffusion rule is of interest be-
cause it shows that when a molecule diffuses then an ODE is not sufficient, and it
becomes a PDE for that molecule variable. These rules all use generic functions like
hillFunction, linearFunction, bindFunction, etc., and these can be specified in more
detail elsewhere which allow for different and alternative dynamics to be modeled.
The flexibility of Maude rewrite rules allows for complex transformations to be
described. There could be situations whereby the method required for two biological
statements together is different from either of those biological statements modeled in
isolation. These situations typically arise at the interfaces between modeling meth-
ods such as with hybrid models that integrate continuous and discrete methods. For
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example, if a cell secretes a molecule into the extracellular space, then there is an in-
terface between the cell model and the extracellular spatial model that describes how
variables in the cell model relate the context of the secrete operation to variables in
the extracellular spatial model. If the cell or the extracellular space were specified as
individual models, then there would be no need for an explicit representation of the
interface between the two models. Rewrite rules can be generated that describe how
the interface between different modeling methods should be performed, and those
rules can be specialized for a particular biological process. For the secrete operation
in Fig. 5, the rules describe a continuous model, so both the cell and the extracellular
space are coupled by variables in a set of ODEs.
2.1.7 Model specification construction
There are numerous techniques for computational modeling of biological phenom-
ena. Broad categories include continuous versus discrete and deterministic versus
stochastic. Multiple categories can often represent the same biology. For example,
molecular interactions can be modeled with ordinary differential equations, a contin-
uous deterministic description, or with stochastic chemical kinetics, which is a dis-
crete stochastic description. As the CMA develops a plan for the specification of the
biological model these different modeling techniques correspond to alternative plans:
thus there is not a single representation of the biological model but rather numerous
potential representations. The CMA provides these alternatives to the researcher such
that one or more can be chosen for implementation.
Construction of the model specification is designed as a planning task. The initial
state of the task is the set of Maude logical statements representing the conceptual
biological model as in Fig. 4. The goal state is a model specification where all of
the statements from the conceptual biological have been accounted for in the list of
potential computational models. Planning fails if there are one or more biological
statements that could not be transformed into a modeling method. This could be due
to the lack of a mapping rule for that particular biological entity or process into a
M&S method. The CMA uses the Maude search command to find all possible so-
lutions to complete model specifications from the initial biological statements. The
search command uses a standard breadth-first search as an inference algorithm that
selects mapping rewrite rules to be applied to the set of Maude logical statements,
and incrementally constructs the model specification as each mapping rewrite rule is
applied. The algorithm creates a state transition graph where goal states correspond
to complete model specifications, and a path from the initial state to a particular goal
state is the sequence of mapping rewrite rules for transforming the conceptual biolog-
ical model into a model specification. While Maude uses breadth-first search as the
standard algorithm, its meta-level reflection capabilities allow strategies to be defined
that control the rewriting inference process. Such strategies are written as part of a
mapping rewrite rule, and though they are not required for the examples presented in
this article, the CMA can use strategies for high-order reasoning that cannot be per-
formed with first-order logical inference. Furthermore because the exact sequence of
rules can be recovered, this enables an explanatory description to be provided to the
user about how the biological model was transformed into a computational model,
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Fig. 6 Model specification produced by CMA for gut mucus stratification model
which might be useful for pedagogical or debugging purposes. For the biological
model given in Fig. 4, the CMA produces the model specification show in Fig. 6.



















= H(BmRNA) − B(A,B)
d[AB]
dt






= ∇2AE + D(AB) − k1AE
d[BE]
dt
= ∇2BE + D(AB) − k2BE
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d[ABE]
dt
= ∇2ABE + S(AB) − D(ABE)
where H,S,B and D are the hillFunction, secreteFunction, bindFunction and disso-
ciateFunction functions.
2.1.8 Model parameters
In our example for gut mucus stratification, the model specification uses generic
names for various interaction functions such as hillFunction, bindFunction, etc. How-
ever, these functions can be defined in more detail, allowing the CMA to perform
additional modeling and simulation capabilities. For example, the CMA could query
the number and type of parameters required for each function. That list of parameters
could be passed to another process that executes parameter sweeps for the simulation.
Likewise, the CMA could query existing biological knowledge to find experimentally
determined values such as transcription rates, degradation rates, diffusion rates, etc.
to be used as initial values for those parameters.
2.1.9 Simulation code
The final step for the CMA is to produce simulation code that can be executed from
the model specification. Here the CMA utilizes an ontology categorizing various nu-
merical and simulation methods along with a set of mapping rules to transform the
model specification into simulation code using specific numerical methods. There has
been even less effort devoted to formalizing such numerical and simulation method
knowledge into a machine-readable format, and we are not aware of any existing
ontologies with this information.
Just as with construction of the model specification, multiple numerical methods
can be applied for the simulation of the same model. These alternatives are typically
concerned with computational and stability issues. They play less of a role regarding
interpretation and analysis of the biological model, but they are important for insuring
the simulation produces valid results. For example, a Runge-Kutta 4th-order method
could provide greater stability and a larger time step over the basic Euler method,
though it may have a greater computational cost. CMA might be able to analyze the
parameter values for the model, looking for order of magnitude scale differences that
indicate a stiff system, thus requiring more stable methods to be used. Furthermore,
CMA could take advantage of information about the hardware, thus producing sim-
ulation code that is geared towards a specific computing environment whether it be
a single computer, multi-core processor, parallel MPI cluster, or a GPU. While this
scalability across hardware platforms is not gained for free, over time as the knowl-
edge database of numerical and simulation methods increases, more of this capability
can be provided in an automated fashion.
2.1.10 Alternative hypotheses
One advantage of using an approach such as the CMA is the increased throughput
gained by the ability to easily pose and investigate alternative hypotheses. With our
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gut mucus stratification model, we can consider a slight modification to our model
that still utilizes the mechanism of morphogen gradients. In this alternative hypothe-
sis, A and B are secreted by the cells individually, and protein A diffuses faster than
protein B. Extracellular protein A and B form a complex AB which then decays.
Proteins A and B also decay at some rate, and protein A converts mucus from tight
to loose form as before. The idea behind this model is that the AB complex binding
prevents protein A from converting the mucus near the cells, but the faster diffusion
rate of protein A means it accumulates in greater concentration than protein B fur-
ther from the cells, thus allowing mucus conversion to occur. This alternative model
would remove statements 11–14 from the original hypothesis, and add the following
statements.
1. Goblet cell secretes [GO:0046903] A protein into extracellular space
[GO:0005615].
2. Goblet cell secretes [GO:0046903] B protein into extracellular space
[GO:0005615].
3. Extracellular A protein and B protein bind [SBO:0000177] to form AB complex
[SBO:0000296].
4. Extracellular AB complex decays [SBO:0000179].
The CMA could readily generate a new model specification and simulation code for
this alternative hypothesis. Furthermore, the CMA could carry over parameter val-
ues and choices made regarding the original model specification and implementation
methods to the alternative model, thus ensuring a close correspondence and effective
comparison of the results predicted by the two simulations. By reducing the degree
of implementation detail required, the CMA allows the researcher to maintain focus
at the level of the biological model during the course of exploring model possibility-
space. This type of computational augmentation of the hypothesis evaluation stage
would facilitate the parallelization of identifying plausible mechanisms and aid in
reducing the process bottleneck present in biomedical research.
2.1.11 Biological Example #2
Having described the general process by which the CMA can semi-automate the
translation of a biological model into a computational one, we present another ex-
ample that uses a different target M&S method. In this case, the biological model
being transformed is that of an intracellular pathway that involves receptor activa-
tion, signal transduction, gene transcription and protein synthesis. While many path-
ways of this sort have been modeled using ODEs, in the interest of demonstrating
the capabilities of the CMA we choose a discrete alternative, Petri nets, to the deter-
ministic continuous ODE. Petri nets are a graph-based modeling formalism that has
been used for mathematical modeling of molecular pathways and networks, and are a
popular means of capturing stochastic and qualitative dynamics from such pathways
(Chaouiya 2007; Goss and Peccoud 1998). For our example we will use a virulence
factor activation pathway found in the bacteria, Pseudomonas aeruginosa.
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2.1.12 Virulence activation in Pseudomonas aeruginosa by the host immune
response
The bacterial species P. aeruginosa is a gram negative bacillus that is one of the
most dangerous bacteria in terms of hospital acquired infection (Obritsch et al. 2005).
P. aeruginosa is noted for its ability to develop resistance to antibiotics as well as ac-
tivate a series of virulence mechanisms causing it to change from a relatively benign
species to a dangerous one. P. aeruginosa is normally found in the colon of healthy
humans, being one of the multitude of microbial species that reside in the human in-
testinal tract. Under normal healthy circumstances, there is no adverse consequence
resulting from the presence of P. aeruginosa in the host colon. However, recently
P. aeruginosa virulence expression has been identified as responding to host tissue
factors released by the gut in response to physiologic stresses seen in hospitalized
patients, such as immune activation (Wu et al. 2005). For purposes of our example
for the CMA we will focus on the sensing of host immune response factor, interferon-
γ (IFN-γ ), and the subsequent virulence pathway activated in response to bacterial
binding of IFN-γ . It has been identified that in P. aeruginosa, the immune mediator,
interferon-γ induces the expression of virulence factors that in turn reduce host de-
fenses (Wu et al. 2005). IFN-γ binding to outer bacterial membrane receptor OprF
activates the expression of PA-I lectin, a compound secreted by P. aeruginosa that
attacks the connections between intestinal epithelial cells, leading to breakdown of
gut barrier defenses and allowing potential bacterial invasion. Up regulation of the
transcription factor RhlI during exposure to IFN-γ represents an intermediate step
between the molecular signaling and gene activation (the target regions being iden-
tified as Lux box for the promoter gene region and LecA as the coding gene region)
leading to the production of PA-I lectin.
Using the same, near-natural language syntax described previously above, the bi-
ological model of the immune activation of PA-I production is as follows:
1. Pseudmonas is a bacteria
2. Pseudomonas has OprF [VO:0012360]
3. OprF [VO:0012360] is a receptor [SBO:000024]
4. Interferon-γ bind to [SBO:0000177] OprF [VO:0012360] to form Interferon-γ -
OprF-complex [SBO:0000179]
5. Interferon-γ -OprF-complex decays
6. Interferon-γ is a ligand [SBO:0000280]
7. Pseudomonas has Rh1RI
8. Rh1RI is a transcription factor [GRO:TranscriptionFactor]
9. Interferon-γ -OprF-complex is a stimulator [SBO:0000459] of Rh1RI
10. Pseudomonas has Lux box
11. Lux box is a gene regulatory region [SBO:0000369]
12. Rh1RI bind to [SBO:0000177] Lux box to form Rh1RI-Lux box-complex
13. Rh1RI-Lux box-complex disassociates into Rh1RI and [SBO:0000177] Lux box
14. Pseudomonas has LecA
15. LecA is a gene [SBO:0000243]
16. Rh1RI-Lux box-complex positively regulates transcription
[GRO:PositiveRegulationOfTranscriptionByTranscriptionActivator] of LecA
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17. LecA is transcribed [SBO:0000183] into PA-I lectin mRNA
18. PA-I lectin mRNA is translated [SBO:0000184] into PA-I lectin
19 PA-I lectin mRNA decays
20. Pseudomonas secretes [GO:0030528] PA-I lectin into extracellular compartment
[GO:0005615].
2.1.13 Mapping rules and model specification creation
As in the process delineated above, the virulence pathway biological model was pre-
sented to the CMA, translated into a set of Maude logical statements, and then the
application of the Maude logical rewrite rules shown in Fig. 7 produced a Petri net
model. The resulting model is shown in Fig. 8.
It should be noted that an additional output of this process was an error statement:
“polypeptide chain” entities “OprF,” “interferon-gamma,” “RhlRI,” has no “trans-
late”
This statement resulted from the fact that some of the entities listed in the bio-
logical model did not have a rule leading to their production. However, rather than
considering this error statement as rendering the biological model invalid, these enti-
ties would be presented back to the researcher as variables in the model that require
initialization values; i.e. the input values for simulation execution.
The above model specification can be described in standard notation for biochem-
ical rules:
PA-I-lectin-mRNA → ∅
PA-I-lectin-mRNA → PA-I-lectin-mRNA + PA-I-lectin
PA-I-lectin → PA-I-lectin[e]
interferon-OprF-complex → ∅
interferon-OprF-complex → interferon-OprF-complex + RhlRI
RhlRI-Lux-box-complex → Lux-box + RhlRI
OprF + interferon-gamma → interferon-OprF-complex
Lux-box + RhlRI → RhlRI-Lux-box-complex
lecA + RhlRI-Lux-box-complex → lecA + RhlRI-Lux-box-complex +
PA-I-lectin-mRNA
As with the gut mucus model example, the conversion of the base Petri net model
into simulation code would involve a selection by the researcher among a set of
subcategories of Petri nets based on their specific properties, such as deterministic
or stochastic, and the characteristics of the system under study. Furthermore, as de-
scribed in Example #1, the CMA could also have generated an ODE model of the
virulence activation pathway; in practice, the biological model of virulence activa-
tion would have been inputted into the CMA and both a Petri net and an ODE model
(among, perhaps, other types) would be generated, each with suggested parameters
based on the requirements of the particular modeling method, and the researcher
would select one or the other (or perhaps even both) based on the initialization data
available or the desired dynamics to be investigated. Additionally, future develop-
ment of the CMA would include the capability to parse the biological model and
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Fig. 7 Maude rewrite rules that describe how various biological statements are translated into a Petri net
model specification. Variables such A, B, C G, TG, S and M are declared as specific Maude sorts related
either to the biological model or the modeling method
determine which components of the model would be suitably represented with de-
terministic methods (such as signal transduction) and which components would be
best represented with stochastic approaches (such as gene binding and activation),
resulting in a hybrid method model.
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Fig. 8 Petri net model specification produced by CMA for the Pseudomonas aeruginosa virulence acti-
vation pathway. The Petri net model is composed of a set of variables for the biological entities (places in
Petri net formalism) and a set of transition rules. The transitions consist of pre-conditions, post-conditions,
and a rate function currently defined as constantFunction. The initial state is defined outside of the model
specification
3 Summary
In this paper we present a description of how a semi-intelligent computational agent
can augment the process of computational biological model construction by utilizing
bio-medical and M&S ontologies to generate simulation code for dynamic knowledge
representation. We suggest that the use of a CMA can aid in addressing the current
throughput issues facing the biomedical research community regarding hypothesis
instantiation, verification and validation. As noted above, the eventual goal of the
computational solution to the Translational Dilemma will require the expansion of
the CMA’s planning and analysis capabilities to include model behavior assessment,
anomaly identification, suggesting alternative hypotheses/solutions and the design
of putative experiments to evaluate these new hypotheses, and scientific workflows
(Hull et al. 2006; Zytkow et al. 1992; Yilmaz and Hunt 2011; Bridewell et al. 2006;
Linke et al. 2011; Goecks et al. 2010). However, achieving these goals will require
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biological knowledge to be in a formal, computable format such that a wide range
of machine learning, model checking, automated inference and AI-planning meth-
ods can be employed. Therefore, the current developmental focus of the CMA is on
the necessary first step of enhancing the conversion of biological knowledge into the
computational and mathematical formal structures that would allow for the develop-
ment and implementation of these capabilities. As such the CMA represents a poten-
tially robust and scalable strategy for enhancing the utilization of dynamic computa-
tional models by the general biomedical research community via semi-automation of
the specification-mapping work associated with computational model development.
By utilizing the meta-programming capabilities of the Maude system, specifically
related to its rewriting logic and reflection properties, the CMA leverages ongoing
development in bio-ontologies, formal knowledge representation and M&S meth-
ods to facilitate the generation of simulation code. It is important to recognize that
while the overall translational goal cannot be achieved using only logic-based sys-
tems, the implementation of computational models using logical inference can aid in
achieving the greater research goal of instantiating conceptual models. Treating the
steps of the model construction process as a planning task can improve the modular-
ity, robustness and scalability of knowledge integration through the introduction of a
new class of meta-programming semi-intelligent computational agents. This would
allow the focusing of future development on the CMA’s inference instruction set.
Given its role as a “translator” between biological models and M&S methods, fu-
ture research can be targeted at advancing the CMA’s capabilities and expressiveness
while maintaining interoperability with established but ongoing development in the
areas of formal semantics/knowledge representation and M&S methods. From the bi-
ological side, future development of the CMA would include the ability to read and
integrate models expressed in XML and Resource Description Framework (RDF)
compatible formats (Cuellar et al. 2003; Hedley et al. 2000; Bullivant et al. 2001;
Hucka et al. 2003). This would allow leveraging of existing model repositories ex-
pressed in those markup languages being used to standardize model sharing in the
biomedical community, such as Systems Biology Markup Language (SBML) (Hucka
et al. 2003) and Cell Markup Language (CellML) (Cuellar et al. 2003). Development
from the M&S community has a bit farther to go, though OpenMath and MathML
may provide the initial steps toward cataloging M&S methods in a computable form.
We believe that the process automation advances offered by the CMA will lead to-
wards the development of cyber-environments providing scalable high-throughput
hypothesis evaluation.
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